Drug Profile
Research programme: serotonin reuptake inhibitors - Pfizer
Alternative Names: UK-373911Latest Information Update: 05 Aug 2009
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder; Stress incontinence
Most Recent Events
- 05 Aug 2009 No development reported - Preclinical for Depression in United Kingdom (unspecified route)
- 05 Aug 2009 No development reported - Preclinical for Stress incontinence in United Kingdom (unspecified route)